First Time Loading...

Amphastar Pharmaceuticals Inc
NASDAQ:AMPH

Watchlist Manager
Amphastar Pharmaceuticals Inc Logo
Amphastar Pharmaceuticals Inc
NASDAQ:AMPH
Watchlist
Price: 41.11 USD 0.69% Market Closed
Updated: Apr 29, 2024

Amphastar Pharmaceuticals Inc
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Amphastar Pharmaceuticals Inc
Cash from Operating Activities Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Amphastar Pharmaceuticals Inc
NASDAQ:AMPH
Cash from Operating Activities
$183.5m
CAGR 3-Years
47%
CAGR 5-Years
37%
CAGR 10-Years
19%
Johnson & Johnson
NYSE:JNJ
Cash from Operating Activities
$22.8B
CAGR 3-Years
-2%
CAGR 5-Years
1%
CAGR 10-Years
2%
Bristol-Myers Squibb Co
NYSE:BMY
Cash from Operating Activities
$13.9B
CAGR 3-Years
0%
CAGR 5-Years
18%
CAGR 10-Years
15%
Pfizer Inc
NYSE:PFE
Cash from Operating Activities
$8.7B
CAGR 3-Years
-15%
CAGR 5-Years
-11%
CAGR 10-Years
-7%
Merck & Co Inc
NYSE:MRK
Cash from Operating Activities
$13B
CAGR 3-Years
8%
CAGR 5-Years
4%
CAGR 10-Years
1%
Eli Lilly and Co
NYSE:LLY
Cash from Operating Activities
$4.2B
CAGR 3-Years
-13%
CAGR 5-Years
-5%
CAGR 10-Years
-3%

See Also

What is Amphastar Pharmaceuticals Inc's Cash from Operating Activities?
Cash from Operating Activities
183.5m USD

Based on the financial report for Dec 31, 2023, Amphastar Pharmaceuticals Inc's Cash from Operating Activities amounts to 183.5m USD.

What is Amphastar Pharmaceuticals Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
19%

Over the last year, the Cash from Operating Activities growth was 106%. The average annual Cash from Operating Activities growth rates for Amphastar Pharmaceuticals Inc have been 47% over the past three years , 37% over the past five years , and 19% over the past ten years .